Jeffrey Seow - Concepedia

Author

Jeffrey Seow

King's College London ORCID

Also Known As

J Seow, J. Seow, JEFFREY TIEN-JIE SEOW, Jeff Seow, Jeffrey Seow, Jia X Seow, Wadge, Samuel, jeffrey seow

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

King's College London Guy's and St Thomas' NHS Foundation Trust University College London The Francis Crick Institute University of Amsterdam

About

Jeffrey Seow is an author at King's College London specializing in medicine, immunology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.4K
2	Public Health	3	3	112
3	Allergy	1	1	75
4	Cell Biology	1	1	75
5	Diabetes	1	1	73

Jeffrey Seow

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans Jeffrey Seow, Carl Graham, Blair Merrick, Nature Microbiology	2020	1.4K
A dynamic COVID-19 immune signature includes associations with poor prognosis Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio, Nature Medicine	2020	1K
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz, The Lancet Oncology	2021	608
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection Michael J. Carter, Matthew Fish, A.R. Jennings, Nature Medicine Primary ImmunodeficiencyMultisystem Inflammatory SyndromeSars-cov-2 InfectionMedicineImmunology	2020	430
Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection Jeffrey Seow, Carl Graham, Blair Merrick, Abstract AntibodyLong CovidViral PersistenceViral DiagnosticsDisease Severity	2020	364
The effect of spike mutations on SARS-CoV-2 neutralization Chloe Rees-Spear, Luke Muir, Sarah Griffith, Cell Reports	2021	240
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant Carl Graham, Jeffrey Seow, Isabella Huettner, Immunity	2021	165
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity Annachiara Rosa, Valerie E. Pye, Carl Graham, Science Advances	2021	154
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings Suzanne Pickering, Gilberto Betancor, Rui Pedro Galão, PLoS Pathogens	2020	120
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern Liane Dupont, Luke B. Snell, Carl Graham, Nature Microbiology	2021	116

Page 1